(2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide

C22H22FN5O4 — CID 162738688

IUPAC(2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide
SMILESCn1c(=O)oc2ccc(-c3cc(F)c(CC(C#N)NC(=O)[C@@H]4CNCCCO4)cn3)cc21
InChIInChI=1S/C22H22FN5O4/c1-28-18-8-13(3-4-19(18)32-22(28)30)17-9-16(23)14(11-26-17)7-15(10-24)27-21(29)20-12-25-5-2-6-31-20/h3-4,8-9,11,15,20,25H,2,5-7,12H2,1H3,(H,27,29)/t15?,20-/m0/s1
InChIKeyUAMQZZHEAQSCEG-MBABXSBOSA-N
MW439.45 g/mol
LogP1.26
Rot. Bonds5

About (2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide

(2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide (PubChem CID 162738688) has the molecular formula C22H22FN5O4 and a molecular weight of 439.45 g/mol. Its IUPAC name is (2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide.

Molecular Properties

Compound Name(2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide
PubChem CID162738688
Molecular FormulaC22H22FN5O4
Molecular Weight439.45 g/mol
Exact Mass439.17
IUPAC Name(2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide
SMILESCn1c(=O)oc2ccc(-c3cc(F)c(CC(C#N)NC(=O)[C@@H]4CNCCCO4)cn3)cc21
InChIInChI=1S/C22H22FN5O4/c1-28-18-8-13(3-4-19(18)32-22(28)30)17-9-16(23)14(11-26-17)7-15(10-24)27-21(29)20-12-25-5-2-6-31-20/h3-4,8-9,11,15,20,25H,2,5-7,12H2,1H3,(H,27,29)/t15?,20-/m0/s1
InChIKeyUAMQZZHEAQSCEG-MBABXSBOSA-N
XLogP1.26
TPSA122.18 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms32
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500439.45
LogP ≤ 51.26
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze (2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide?
The IUPAC name of (2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide (CID 162738688) is (2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide.
What is the SMILES notation for (2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide?
The canonical SMILES for (2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide is Cn1c(=O)oc2ccc(-c3cc(F)c(CC(C#N)NC(=O)[C@@H]4CNCCCO4)cn3)cc21.
What is the InChIKey of (2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide?
The InChIKey is UAMQZZHEAQSCEG-MBABXSBOSA-N. The full InChI is InChI=1S/C22H22FN5O4/c1-28-18-8-13(3-4-19(18)32-22(28)30)17-9-16(23)14(11-26-17)7-15(10-24)27-21(29)20-12-25-5-2-6-31-20/h3-4,8-9,11,15,20,25H,2,5-7,12H2,1H3,(H,27,29)/t15?,20-/m0/s1.
What are the key properties of (2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide?
(2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide has a molecular weight of 439.45 g/mol, XLogP of 1.26, 5 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[1-cyano-2-[4-fluoro-6-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)-3-pyridinyl]ethyl]-1,4-oxazepane-2-carboxamide is sourced from PubChem (CID 162738688), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).